- Home
- NCRA vs TLPH Comparison
NCRA vs TLPH Comparison
Compare NCRA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCRA | TLPH |
|---|---|---|
| Founded | 2002 | 2005 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 64.7M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | NCRA | TLPH |
|---|---|---|
| Price | $0.95 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 76.3K | ★ 365.3K |
| Earning Date | 04-01-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,106,275.00 | $28,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14,267.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.75 | $0.38 |
| 52 Week High | $2.40 | $1.57 |
Technical Indicators
Market Signals| Indicator | NCRA | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 39.61 | 36.72 |
| Support Level | $0.82 | $1.20 |
| Resistance Level | $1.33 | $1.25 |
| Average True Range (ATR) | 0.13 | 0.09 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 10.98 | 7.09 |
Price Performance
Historical ComparisonAbout NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.